Eruptive squamous cell carcinomas with keratoacanthoma-like features in a patient treated with sorafenib

Michael C Lynch1, Renee Straub, David R Adams

  • 1Pennsylvania State University College of Medicine, Hershey, PA, USA.

Insights

Sorafenib, a cancer drug, can cause skin cancers like squamous cell carcinoma and keratoacanthoma. Regular skin checks are crucial for patients undergoing sorafenib treatment to detect these side effects early.

Area of Science:

  • Oncology
  • Dermatology

Background:

  • Sorafenib is a multikinase inhibitor used for advanced cancers like hepatocellular carcinoma and renal cell carcinoma.
  • It offers survival benefits but can cause dermatologic side effects.

Observation:

  • A case study details a patient with hepatocellular carcinoma who developed eruptive squamous cell carcinomas with keratoacanthoma-like features.
  • These skin cancers were induced by sorafenib treatment.

Findings:

  • The case supports a link between sorafenib and non-melanoma skin cancers, specifically squamous cell carcinoma and keratoacanthoma.
  • Sorafenib's side effect profile includes various skin issues, with this case highlighting a rarer, more serious manifestation.

Implications:

  • Routine dermatologic monitoring is recommended for patients on sorafenib.
  • Early detection of sorafenib-induced skin cancers is vital for patient management and outcomes.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...